Total Payments
$1,719
2024 Payments
$286.72
Companies
31
Transactions
107
Medicare Patients
3,101
Medicare Billing
$311,028
Payment Breakdown by Category
Food & Beverage$1,685 (98.0%)
Education$34.42 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,685 | 105 | 98.0% |
| Education | $34.42 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $376.55 | 32 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $138.09 | 6 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $120.37 | 4 | $0 (2022) |
| SK Life Science, Inc. | $84.60 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $79.24 | 4 | $0 (2024) |
| Lilly USA, LLC | $73.24 | 5 | $0 (2024) |
| Genentech USA, Inc. | $64.75 | 5 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $59.85 | 3 | $0 (2022) |
| EMD Serono, Inc. | $56.42 | 4 | $0 (2021) |
| Allergan, Inc. | $52.86 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $286.72 | 17 | ABBVIE INC. ($146.51) |
| 2023 | $237.06 | 22 | AbbVie Inc. ($130.63) |
| 2022 | $184.52 | 10 | ABBVIE INC. ($58.90) |
| 2021 | $196.33 | 12 | Janssen Pharmaceuticals, Inc ($37.35) |
| 2020 | $81.96 | 5 | E.R. Squibb & Sons, L.L.C. ($37.04) |
| 2019 | $294.40 | 18 | Novartis Pharmaceuticals Corporation ($41.54) |
| 2018 | $262.26 | 13 | Neurocrine Biosciences, Inc. ($60.03) |
| 2017 | $175.94 | 10 | Alexion Pharmaceuticals, Inc. ($45.29) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/23/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Central Nervous System | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Neurology | ||||||
| 07/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Neurology | ||||||
| 06/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/16/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $26.39 | General |
| 05/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/20/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Neuroscience | ||||||
| 11/02/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 679 | 876 | $230,283 | $71,953 |
| 2022 | 14 | 860 | 1,063 | $267,821 | $85,861 |
| 2021 | 12 | 700 | 892 | $212,487 | $75,336 |
| 2020 | 16 | 862 | 1,063 | $243,622 | $77,877 |
Total Patients
3,101
Total Services
3,894
Medicare Billing
$311,028
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 248 | 346 | $86,137 | $29,928 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 137 | 172 | $28,602 | $10,615 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $22,666 | $7,069 | 31.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 53 | 78 | $15,520 | $5,352 | 34.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 28 | 28 | $18,602 | $4,283 | 23.0% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 40 | 79 | $12,165 | $3,406 | 28.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $9,284 | $3,039 | 32.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 15 | 15 | $11,364 | $2,741 | 24.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 19 | 19 | $9,207 | $1,924 | 20.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 12 | 12 | $6,870 | $1,422 | 20.7% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2023 | 20 | 20 | $5,724 | $1,253 | 21.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 11 | 11 | $4,142 | $921.50 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 252 | 334 | $80,818 | $28,510 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 227 | 279 | $44,980 | $16,114 | 35.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 69 | 92 | $17,746 | $6,415 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 41 | $13,363 | $5,190 | 38.8% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 27 | 27 | $17,432 | $4,435 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $14,390 | $3,928 | 27.3% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 38 | 80 | $12,012 | $3,786 | 31.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 48 | 48 | $11,666 | $3,780 | 32.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 30 | 30 | $14,072 | $3,055 | 21.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $7,916 | $2,663 | 33.6% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 12 | 12 | $8,782 | $2,367 | 26.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 18 | 18 | $10,021 | $2,150 | 21.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 20 | 21 | $7,667 | $1,895 | 24.7% |
About Dr. Robert Ward, D.O
Dr. Robert Ward, D.O is a Neurology healthcare provider based in Saint Joseph, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598762379.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Ward, D.O has received a total of $1,719 in payments from pharmaceutical and medical device companies, with $286.72 received in 2024. These payments were reported across 107 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($1,685).
As a Medicare-enrolled provider, Ward has provided services to 3,101 Medicare beneficiaries, totaling 3,894 services with total Medicare billing of $311,028. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Saint Joseph, MI
- Active Since 07/07/2005
- Last Updated 02/21/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1598762379
Products in Payments
- QULIPTA (Drug) $180.59
- BOTOX (Biological) $164.62
- SOLIRIS (Drug) $138.09
- INGREZZA (Drug) $100.99
- ZEPOSIA (Drug) $80.44
- OCREVUS (Biological) $51.62
- Briviact (Drug) $49.75
- MAYZENT (Drug) $41.54
- Hizentra (Biological) $41.09
- EMGALITY (Drug) $40.70
- Mavenclad (Biological) $38.70
- LIORESAL (BACLOFEN) (Drug) $36.57
- UBRELVY (Drug) $32.11
- KYNMOBI (Drug) $32.03
- XCOPRI (Drug) $31.69
- VYVGART (Drug) $25.21
- Duopa (Drug) $23.95
- Leqembi (Drug) $23.95
- Aimovig (Biological) $21.13
- MYOBLOC (Biological) $21.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Saint Joseph
David Ewing, Md, MD
Neurology — Payments: $50,829
Neurology $50,829
Abdallah Amireh, Md, MD
Neurology — Payments: $2,376
Neurology $2,376
Chelsea Meyer, D.o, D.O
Neurology — Payments: $1,788
Neurology $1,788
Dr. Peter Spencer, D.o, D.O
Neurology — Payments: $1,615
Neurology $1,615
Dr. Holly Clausen, Phd, Lp, PHD, LP
Neurology
Neurology